In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains-Reference-Cited by-同舟云学术

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Published:2021-06-21 Issue:7870 Volume:596 Page:103-108
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Chen Rita E.,Winkler Emma S.,Case James Brett^ORCID,Aziati Ishmael D.,Bricker Traci L.,Joshi Astha^ORCID,Darling Tamarand L.,Ying Baoling,Errico John M.^ORCID,Shrihari Swathi,VanBlargan Laura A.,Xie Xuping^ORCID,Gilchuk Pavlo,Zost Seth J.^ORCID,Droit Lindsay,Liu Zhuoming^ORCID,Stumpf Spencer,Wang David,Handley Scott A.,Stine W. Blaine,Shi Pei-Yong^ORCID,Davis-Gardner Meredith E.,Suthar Mehul S.,Knight Miguel Garcia,Andino Raul^ORCID,Chiu Charles Y.^ORCID,Ellebedy Ali H.^ORCID,Fremont Daved H.^ORCID,Whelan Sean P. J.^ORCID,Crowe James E.^ORCID,Purcell Lisa,Corti Davide^ORCID,Boon Adrianus C. M.^ORCID,Diamond Michael S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-021-03720-y.pdf

Reference45 articles.

1. Chen, R. E. et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. 27, 717–726 (2021).

2. Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130–135 (2021).

3. Wang, Z. et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 592, 616–622 (2021).

4. Wibmer, C. K. et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat. Med. 27, 622–625 (2021).

5. Tada, T. et al. Convalescent-phase sera and vaccine-elicited antibodies largely maintain neutralizing titer against global SARS-CoV-2 variant spikes. mBio 12, https://doi.org/10.1128/mBio.00696-21 (2021).

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection;Journal of Virology;2024-08-29

2. Fibrin drives thromboinflammation and neuropathology in COVID-19;Nature;2024-08-28

3. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case;Microbiology Spectrum;2024-08-06

4. Outpatient Intravenous Remdesivir to Prevent Progression to Severe COVID-19: An Observational Study from a Greek Hospital;Recent Advances in Anti-Infective Drug Discovery;2024-08

5. A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants;Frontiers in Immunology;2024-07-19